Close
New

Medscape is available in 5 Language Editions – Choose your Edition here.

 

Simple Partial Seizures Treatment & Management

  • Author: Jane G Boggs, MD; Chief Editor: Selim R Benbadis, MD  more...
 
Updated: Feb 22, 2016
 

Approach Considerations

Benign focal epilepsy of childhood is usually a self-limited condition; if no seizures with secondarily generalization occur, patient care need not include antiepilepsy drugs (AEDs). In other patients, AED treatment is appropriate for simple partial seizures (SPS). Selected patients with SPS refractory to AEDs may be candidates for surgical treatment.

Go to Epilepsy and Seizures for an overview of this topic.

Next

Antiepileptic Drug Therapy

Numerous AEDs currently are approved worldwide with indications for SPS, and others are in development. No one drug of choice is recommended for SPS, since in clinical trials all the drugs have demonstrated similar levels of efficacy. Selection of the most appropriate medication is based on potential side effects, dosing schedules, available formulations, and individual factors.[16, 17, 18, 19, 20]

Go to Antiepileptic Drugs for complete information on this topic.

Previous
Next

Surgical Care

Patients with medically refractory seizures may be candidates for epilepsy surgery, especially if they have a well-localized seizure onset documented by video-EEG and a corresponding lesion on neuroimaging. Such cases should be carefully evaluated preoperatively with the resection properly planned by the epilepsy surgical team to minimize the risk of postoperative deficit.

Focal cortical resection, amygdalo-hippocampectomy, lesionectomy, thermal laser ablation, or gamma knife surgery may be the most appropriate procedure. The specific procedure should be tailored individually to the features of each case. Implantable responsive neurostimulation (RNS) can be an alternative to focal resection in some patients.

Rasmussen encephalitis responds poorly to medical treatment and usually is treated by hemispherectomy to prevent involvement of the contralateral hemisphere.

Patients whose seizures are medically refractory but are not good candidates for epilepsy surgery may be candidates for implantation of a device to provide vagus nerve stimulation.

Go to Epilepsy Surgery for complete information on this topic.

Previous
Next

Treatment During Pregnancy

Although often perceived to be less severe than complex partial and generalized seizures, SPS in pregnancy can be associated with fetal distress. Every effort must be made to control seizures during pregnancy by using appropriate doses of the most successful agent for the individual. If possible, avoid AED drug changes.

Go to Women's Health and Epilepsy for complete information on this topic.

Previous
Next

Consultations

Cardiac, gastrointestinal, psychiatric, or endocrine consultation, depending on individual cases, may be necessary in diagnostically difficult cases.

Psychiatric consultation may be necessary for management of concurrent depression, anxiety, and/or non-epileptic events.

Previous
Next

Diet

Although a ketogenic diet has been used successfully in refractory seizures, it is not used commonly for patients exhibiting SPS exclusively (except children) who are not responding to medication.[21]

The medium-chain triglyceride diet is more convenient and palatable, and it does not result in hypercholesterolemia, although it appears to be less successful in the treatment of refractory seizures.[22] The Atkins diet has also been reported to have some adjunctive benefit to some patients with refractory seizures.[23]

Previous
Next

Activity

As SPS do not impair consciousness, activity may not need to be restricted severely as with other types of seizures. Compliant patients with a consistent, exclusively SPS pattern that does not interfere with the ability to manipulate the controls of a motor vehicle are legally allowed to drive in states in which the motor vehicle authority approves exceptions to complete seizure control. Compliance with state guidelines may require self-reporting by patients or specific documentation of patient symptoms, compliance, and medications by the treating physician.

The safety of swimming and other potentially hazardous recreational or employment activities should be evaluated on an individual basis. The ability of an affected patient to care for infants in an unsupervised setting should be evaluated on an individual basis.

Previous
Next

Long-Term Monitoring

At least monthly outpatient follow-up is recommended when seizures are not well controlled. As seizure control improves, the interval between evaluations can be increased.

Seizure-free patients may be monitored by a neurologist once or twice annually. Outpatient laboratory studies should be performed to monitor metabolic effects of the medications used to treat SPS, and to monitor underlying medical conditions.

AED levels should be performed when toxicity is suspected, or to confirm adequate compliance or absorption of medications. In the absence of side effects of medication, metabolic changes, or breakthrough seizures, routine monitoring of AED levels usually is not justified.

Patients diagnosed with SPS may require follow-up inpatient care if new patterns of seizures develop. EEG or video-EEG studies are often necessary to clarify the nature of the new seizure type. Neuroimaging and laboratory studies may help in identifying reasons for seizure exacerbations. In addition, medications usually can be adjusted more quickly in inpatients, and hospitalization in a video-EEG-monitoring unit optimizes the safety of rapid adjustment in the doses of medication.

Previous
 
 
Contributor Information and Disclosures
Author

Jane G Boggs, MD Associate Professor of Neurology, Wake Forest University School of Medicine; Clinical Associate Professor, Virginia Commonwealth University School of Medicine, Medical College of Virginia

Jane G Boggs, MD is a member of the following medical societies: American Academy of Neurology, American Clinical Neurophysiology Society, American Epilepsy Society

Disclosure: Nothing to disclose.

Specialty Editor Board

Francisco Talavera, PharmD, PhD Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Received salary from Medscape for employment. for: Medscape.

Chief Editor

Selim R Benbadis, MD Professor, Director of Comprehensive Epilepsy Program, Departments of Neurology and Neurosurgery, Tampa General Hospital, University of South Florida College of Medicine

Selim R Benbadis, MD is a member of the following medical societies: American Academy of Neurology, American Medical Association, American Academy of Sleep Medicine, American Clinical Neurophysiology Society, American Epilepsy Society

Disclosure: Serve(d) as a director, officer, partner, employee, advisor, consultant or trustee for: Cyberonics; Eisai; Lundbeck; Sunovion; UCB; Upsher-Smith<br/>Serve(d) as a speaker or a member of a speakers bureau for: Cyberonics; Eisai; Glaxo Smith Kline; Lundbeck; Sunovion; UCB<br/>Received research grant from: Cyberonics; Lundbeck; Sepracor; Sunovion; UCB; Upsher-Smith.

References
  1. Engel J Jr. ILAE classification of epilepsy syndromes. Epilepsy Res. 2006 Aug. 70 Suppl 1:S5-10. [Medline].

  2. Gastaut H, Gastaut JL, Goncalves e Silva GE, et al. Relative frequency of different types of epilepsy: a study employing the classification of the International League Against Epilepsy. Epilepsia. 1975 Sep. 16(3):457-61. [Medline].

  3. Salanova V, Van Ness PC, Andermann F. Frontal, parietal and occipital epilepsies. In: Wyllie E, ed. The Treatment of Epilepsy: Principles and Practice. 2nd ed. Baltimore: Williams & Wilkins;. 1997:423-431.

  4. Ajmone-Marsan C, Goldhammer L. Clinical ictal patterns and electrographic data in cases of partial seizures of fronto-central-parietal origin. In: Epilepsy, its Phenomenon in Man. San Diego, Calif: Academic Press; 1973:. 235-58.

  5. Penfield W, Jasper H. In: Epilepsy and the Functional Anatomy of the Human Brain. Boston: Little Brown;. 1954:15-33.

  6. Fish DR, Gloor P, Quesney FL, Olivier A. Clinical responses to electrical brain stimulation of the temporal and frontal lobes in patients with epilepsy. Pathophysiological implications. Brain. 1993 Apr. 116 ( Pt 2):397-414. [Medline].

  7. Benarroch EE. The central autonomic network: functional organization, dysfunction, and perspective. Mayo Clin Proc. 1993 Oct. 68(10):988-1001. [Medline].

  8. Hauser WA, Annegers JF, Kurland LT. Incidence of epilepsy and unprovoked seizures in Rochester, Minnesota: 1935-1984. Epilepsia. 1993 May-Jun. 34(3):453-68. [Medline].

  9. Commission on Classification and Terminology of the International League Against Epilepsy. Proposal for revised classification of epilepsies and epileptic syndromes. Epilepsia. 1989 Jul-Aug. 30(4):389-99. [Medline].

  10. Kotagal P, Luders H. Simple motor seizures. In: Engel J Jr, Pedley TA, eds. Epilepsy: A Comprehensive Textbook. Philadelphia: Lippincott-Raven;. 1998:525-532.

  11. Alexopoulos AV and Dinner DS. Focal motor seizures, Epilepsia partialis continua, and Supplementary Sensorimotor Seizures In: Wyllie E, ed. The Treatment of Epilepsy: Principles and Practice. 4th ed. Baltimore: Williams & Wilkins;. 2006.

  12. Liporace JD, Sperling MR. Simple autonomic seizures. In: Engel J Jr, Pedley T, eds. Epilepsy: A Comprehensive Textbook. Philadelphia: Lippincott-Raven: 1998:. 549-56.

  13. Keilson MJ, Hauser WA, Magrill JP. Electrocardiographic changes during electrographic seizures. Arch Neurol. 1989 Nov. 46(11):1169-70. [Medline].

  14. Kaada BR, Jasper H. Respiratory responses to stimulation of the temporal pole, insula and hippocampal and limbic gyri in man. J Neurophysiol. 1949. 12:385.

  15. Calleja J, Carpizo R, Berciano J. Orgasmic epilepsy. Epilepsia. 1988 Sep-Oct. 29(5):635-9. [Medline].

  16. French JA, Kanner AM, Bautista J, et al. Efficacy and tolerability of the new antiepileptic drugs I: treatment of new onset epilepsy: report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilep. Neurology. 2004 Apr 27. 62(8):1252-60. [Medline].

  17. French JA, Kanner AM, Bautista J, et al. Efficacy and tolerability of the new antiepileptic drugs II: treatment of refractory epilepsy: report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epil. Neurology. 2004 Apr 27. 62(8):1261-73. [Medline].

  18. Glauser T, Ben-Menachem E, Bourgeois B, et al. ILAE treatment guidelines: evidence-based analysis of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes. Epilepsia. 2006 Jul. 47(7):1094-120. [Medline].

  19. Karceski S, Morrell M, Carpenter D. The Expert Consensus Guideline Series: Treatment of Epilepsy. Epilepsy Behav. 2001. 2:A1-A50.

  20. Karceski S, Morrell MJ, Carpenter D. Treatment of epilepsy in adults: expert opinion, 2005. Epilepsy Behav. 2005 Sep. 7 Suppl 1:S1-64; quiz S65-7. [Medline].

  21. Witrow CD. The ketogenic diet: mechanisms of anticonvulsant action. In: Glaser GH, Penry JK, Woodbury DM, eds. Symposium on Mechanisms of Action of Antiepileptic Drugs, St. Louis, Missouri, 1977. New York: Raven Press,. 1980; 27. 635-642.

  22. Huttenlocher PR, Wilbourn AJ, Signore JM. Medium-chain triglycerides as a therapy for intractable childhood epilepsy. Neurology. 1971 Nov. 21(11):1097-103. [Medline].

  23. Kossoff, Eric H and Dorward, Jennifer L. The Modified Atkins Diet. Epilepsia. Nov 2008. 49 (suppl. 8):37-41.

Previous
Next
 
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2016 by WebMD LLC. This website also contains material copyrighted by 3rd parties.